Specifically, it has been shown recently that tau pathology is frequently seen in locus caeruleus (LC), suggesting that AD-associated tau pathology may begin from LC rather than from the trans-entorhinal region (Braak and Del Tredici, 2011; Braak et al., 2011). This evidence concerns the gene MAPT and Alzheimer disease.